A Comparison Between 12 Versus 20 Weeks of Trimethoprim-Sulfamethoxazole as Oral Eradication Treatment for Melioidosis (12vs20): An Open-label, Pragmatic, Multicenter, Non-inferiority, Randomized Controlled Trial
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

A Comparison Between 12 Versus 20 Weeks of Trimethoprim-Sulfamethoxazole as Oral Eradication Treatment for Melioidosis (12vs20): An Open-label, Pragmatic, Multicenter, Non-inferiority, Randomized Controlled Trial

Anunnatsiri, Siriluck;Chaowagul, Wipada;Teparrukkul, Prapit;Chetchotisakd, Ploenchan;Tanwisaid, Kittisak;Khemla, Supphachoke;Narenpitak, Surapong;Pattarapongsin, Moragot;Kongsawasd, Wirod;Pisuttimarn, Pornrith;Thipmontree, Wilawan;Mootsikapun, Piroon;Chaisuksant, Seksan;Chierakul, Wirongrong;Day, Nicholas P J;Limmathurotsakul, Direk;
clinical infectious diseases pp. -
230
siriluckclinicala

Abstract

AbstractBackground. Treatment of melioidosis comprises intravenous drugs for at least 10 days, followed by oral trimethoprim-sulfamethoxazole (TMP-SMX) for 12

Keywords

Access

URL:
https://doi.org/10.1093/cid/ciaa1084

Citation

ID: 111200
Ref Key: siriluckclinicala
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
111200
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
4/5
Blockchain Upload Locked

Complete all 5 checklist items to tokenize your article

Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store